Shenzhen Vivolight Medical Equipment Technology Co., Ltd. announced that it has received CNY 100 million in funding from Shanghai FOSUN Pharmaceutical Co., Ltd., Investment Arm, Sequoia China Investment Management LLP, Xi'an CAS Star Technology Incubator Co., Ltd., Zhuhai Huajin Capital Co., Ltd., Taihe Capital
September 15, 2022
Share
Shenzhen Vivolight Medical Equipment Technology Co., Ltd. announced that it has received over CNY 100,000,000 in a round of funding co-led by Zhuhai Huajin Capital Co., Ltd. and Fosun Health Capital, a fund managed by Shanghai FOSUN Pharmaceutical (Group) Co., Ltd., Investment Arm on September 16, 2022. The transaction included participation from Taihe Capital and returning investors Sequoia China Investment Management LLP and Xi'an CAS Star Technology Incubator Co., Ltd.
Zhuhai Huajin Capital Co. Ltd. specializes in the design, manufacturing and marketing of electronic products. The products include electrolytic capacitors, cabling products, electronic components, software, etc. The group also proposes technologic and computing services (network engineering, training, software development services, etc.) and develops a power production activity.
China accounts for 94.7% of net sales.
Shenzhen Vivolight Medical Equipment Technology Co., Ltd. announced that it has received CNY 100 million in funding from Shanghai FOSUN Pharmaceutical Co., Ltd., Investment Arm, Sequoia China Investment Management LLP, Xi'an CAS Star Technology Incubator Co., Ltd., Zhuhai Huajin Capital Co., Ltd., Taihe Capital
ZHUHAI HUAJIN CAPITAL CO., LTD. 
